Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
LaunchSunflower Therapeutics has launched the Daisy Petal™ Perfusion Bioreactor System through a distribution agreement with PharmNXT Biotech.
Feb 26, 2025
MedfordBiotechnology
Product Description
The commercial launch of the Daisy Petal™ Perfusion Bioreactor System marks a significant milestone for Sunflower Therapeutics as it aims to expand its protein manufacturing solutions in Asia.
Company Information
Company
Sunflower Therapeutics
Location
200 Boston Ave
Medford, Massachusetts, United States
About
Sunflower Therapeutics is a unique biotech with a mission to transform bioeconomies worldwide by creating accessible solutions for protein product development and commercial manufacturing. Using our core technologies – an efficient host, data-driven methods for process development, and continuous biomanufacturing equipment – our team aims to democratize bioprocessing.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sunflower Therapeutics ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.